Related references
Note: Only part of the references are listed.ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Young Hee Choi et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance
Ankit Saneja et al.
EXPERT OPINION ON DRUG DELIVERY (2014)
P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
Tetsuo Yamagishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Screening Compounds with a Novel High-Throughput ABCB1-Mediated Efflux Assay Identifies Drugs with Known Therapeutic Targets at Risk for Multidrug Resistance Interference
Megan R. Ansbro et al.
PLOS ONE (2013)
Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy
Y. Yu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
N-myc downstream regulated gene 1 modulates Wnt-ß-catenin signalling and pleiotropically suppresses metastasis
Wen Liu et al.
EMBO MOLECULAR MEDICINE (2012)
The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)
Zhiqiang Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo
David B. Lovejoy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
David B. Lovejoy et al.
CANCER RESEARCH (2011)
The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
Naseem Akhtar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism
Sowmya V. Yelamanchili et al.
MOLECULAR NEURODEGENERATION (2011)
Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer
Zaklina Kovacevic et al.
MOLECULAR PHARMACOLOGY (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues
A. Banas et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity
Patric J. Jansson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Triggering Liposomal Drug Release With a Lysosomotropic Agent
Subin Xiong et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions
Andrzej Sapota et al.
BIOMETALS (2009)
The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells
V. Ashutosh Rao et al.
CANCER RESEARCH (2009)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Proteomic investigation of taxol and taxotere resistance and invasiveness in a squamous lung carcinoma cell line
L. Murphy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
ABC multidrug transporters: structure, function and role in chemoresistance
Frances J. Sharom
PHARMACOGENOMICS (2008)
Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake
Peter V. E. Van den Berghe et al.
BIOCHEMICAL JOURNAL (2007)
Modulation of the brain distribution of imatinib and its metabolites in mice by valspodar, zosuquidar and elacridar
Sebastien Bihorel et al.
PHARMACEUTICAL RESEARCH (2007)
Design, synthesis, and characterization of novel iron chelators: Structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents
Danuta S. Kalinowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
P. Heffeter et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Multiple molecular mechanisms for multidrug resistance transporters
Christopher F. Higgins
NATURE (2007)
Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique
J. Naga Raju Guntupalli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2007)
A guided tour into subcellular colocalization analysis in light microscopy
S. Bolte et al.
JOURNAL OF MICROSCOPY (2006)
Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity
Des R. Richardson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics
Megan Whitnall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Enhancement of the cytotoxicity of liposomal ricin by the carboxylic ionophore monensin and the lysosomotropic amine NH4Cl in Chinese hamster ovary cells
Seemha Bharadwaj et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2006)
Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multildrug resistance-associated protein 1
Ralph N. Watts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer
Joseph A. Ludwig et al.
CANCER RESEARCH (2006)
Multidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug efflux
CS Morrow et al.
MOLECULAR PHARMACOLOGY (2006)
What kinds of substrates show p-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine
Takuo Ogihara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2006)
Kinetics and mechanisms of DMSO (dimethylsulfoxide) degradation by UV/H2O2 process
Y Lee et al.
WATER RESEARCH (2004)
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment
J Yuan et al.
BLOOD (2004)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
AH Schinkel et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron
ZQ Yu et al.
REDOX REPORT (2003)
The role of ABC transporters in clinical practice
GD Leonard et al.
ONCOLOGIST (2003)
Differential anthracycline sensitivity in two related human colon carcinoma cell lines expressing similar levels of P-glycoprotein
AL Boquete et al.
CANCER LETTERS (2001)
Share Paper
